Director, Chief Executive Officer · Alamar Biosciences, Inc. · Alamar Biosciences, Inc. — Stock Option (Right to Buy)
Side
J
Value
—
Shares
25.3K
Price
—
Executed
Apr 20, 2026
Disclosed
Apr 20, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Apr 20 executedApr 20, 2026 disclosed
ALMR · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Alamar Biosciences, Inc. — Stock Option (Right to Buy)
Ticker
ALMR
Shares
25.3K
Price per share
$0
Execution date (reported)
Apr 20, 2026
Owned after transaction
25.3K shares
Days from execution to publication
0
What this establishes
Luo Yuling filed this Form 4 reporting a other acquisition or disposition of ALMR on Apr 20, 2026. It became public on Apr 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Executive Officer
Luo Yulingcik:0002126941
Issuer
Alamar Biosciences, Inc.cik:0002104204
Revision history · 0
No field has changed since this record was first ingested.
